118 related articles for article (PubMed ID: 38768577)
1. Dysregulation of Plasma Growth Factors and Chemokines in Cocaine Use Disorder: Implications for Dual Diagnosis with Schizophrenia and Antisocial Personality Disorder in an Exploratory Study.
Torres-Galván S; Flores-López M; Ochoa E; Requena-Ocaña N; Araos P; Herrera-Imbroda J; Muga R; Serrano A; Rodríguez de Fonseca F; Pavón-Morón FJ; Haro G; García-Marchena N
Neuropsychobiology; 2024; 83(2):73-88. PubMed ID: 38768577
[TBL] [Abstract][Full Text] [Related]
2. Inflammatory mediators and dual depression: Potential biomarkers in plasma of primary and substance-induced major depression in cocaine and alcohol use disorders.
García-Marchena N; Barrera M; Mestre-Pintó JI; Araos P; Serrano A; Pérez-Mañá C; Papaseit E; Fonseca F; Ruiz JJ; Rodríguez de Fonseca F; Farré M; Pavón FJ; Torrens M
PLoS One; 2019; 14(3):e0213791. PubMed ID: 30870525
[TBL] [Abstract][Full Text] [Related]
3. Plasma concentrations of BDNF and IGF-1 in abstinent cocaine users with high prevalence of substance use disorders: relationship to psychiatric comorbidity.
Pedraz M; Martín-Velasco AI; García-Marchena N; Araos P; Serrano A; Romero-Sanchiz P; Suárez J; Castilla-Ortega E; Barrios V; Campos-Cloute R; Ruiz JJ; Torrens M; Chowen JA; Argente J; de la Torre R; Santín LJ; Villanúa MÁ; Rodríguez de Fonseca F; Pavón FJ
PLoS One; 2015; 10(3):e0118610. PubMed ID: 25734326
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of plasma-free endocannabinoids and their congeners in abstinent cocaine addicts seeking outpatient treatment: impact of psychiatric co-morbidity.
Pavón FJ; Araos P; Pastor A; Calado M; Pedraz M; Campos-Cloute R; Ruiz JJ; Serrano A; Blanco E; Rivera P; Suárez J; Romero-Cuevas M; Pujadas M; Vergara-Moragues E; Gornemann I; Torrens M; de la Torre R; Rodríguez de Fonseca F
Addict Biol; 2013 Nov; 18(6):955-69. PubMed ID: 24283982
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of plasma cytokines in patients with cocaine use disorders in abstinence identifies transforming growth factor alpha (TGFα) as a potential biomarker of consumption and dual diagnosis.
Maza-Quiroga R; García-Marchena N; Romero-Sanchiz P; Barrios V; Pedraz M; Serrano A; Nogueira-Arjona R; Ruiz JJ; Soria M; Campos R; Chowen JA; Argente J; Torrens M; López-Gallardo M; Marco EM; Rodríguez de Fonseca F; Pavón FJ; Araos P
PeerJ; 2017; 5():e3926. PubMed ID: 29038767
[TBL] [Abstract][Full Text] [Related]
6. Plasma profile of pro-inflammatory cytokines and chemokines in cocaine users under outpatient treatment: influence of cocaine symptom severity and psychiatric co-morbidity.
Araos P; Pedraz M; Serrano A; Lucena M; Barrios V; García-Marchena N; Campos-Cloute R; Ruiz JJ; Romero P; Suárez J; Baixeras E; de la Torre R; Montesinos J; Guerri C; Rodríguez-Arias M; Miñarro J; Martínez-Riera R; Torrens M; Chowen JA; Argente J; Mason BJ; Pavón FJ; Rodríguez de Fonseca F
Addict Biol; 2015 Jul; 20(4):756-72. PubMed ID: 24854157
[TBL] [Abstract][Full Text] [Related]
7. Sensorimotor Gating in Cocaine-Related Disorder with Comorbid Schizophrenia or Antisocial Personality Disorder.
Fuertes-Saiz A; Benito A; Mateu C; Carratalá S; Almodóvar I; Baquero A; Haro G
J Dual Diagn; 2019; 15(4):243-253. PubMed ID: 31287382
[No Abstract] [Full Text] [Related]
8. The MCP-1, CCL-5 and SDF-1 chemokines as pro-inflammatory markers in generalized anxiety disorder and personality disorders.
Ogłodek EA; Szota AM; Just MJ; Moś DM; Araszkiewicz A
Pharmacol Rep; 2015 Feb; 67(1):85-9. PubMed ID: 25560580
[TBL] [Abstract][Full Text] [Related]
9. Enhanced peripheral levels of BDNF and proBDNF: elucidating neurotrophin dynamics in cocaine use disorder.
Pettorruso M; Miuli A; Clemente K; Mancusi G; Migliara G; Di Carlo F; Pernaci G; Di Crosta T; Santorelli M; d'Andrea G; De Risio L; Ciavarella M; Baccolini V; Di Meo I; Cataldo I; Sensi SL; Martinotti G
Mol Psychiatry; 2024 Mar; 29(3):760-766. PubMed ID: 38177347
[TBL] [Abstract][Full Text] [Related]
10. Plasma concentrations of granulocyte colony-stimulating factor (G-CSF) in patients with substance use disorders and comorbid major depressive disorder.
Galván ST; Flores-López M; Romero-Sanchiz P; Requena-Ocaña N; Porras-Perales O; Nogueira-Arjona R; Mayoral F; Araos P; Serrano A; Muga R; Pavón FJ; García-Marchena N; de Fonseca FR
Sci Rep; 2021 Jul; 11(1):13629. PubMed ID: 34211033
[TBL] [Abstract][Full Text] [Related]
11. Impact of peripheral levels of chemokines, BDNF and oxidative markers on cognition in individuals with schizophrenia.
Asevedo E; Gadelha A; Noto C; Mansur RB; Zugman A; Belangero SI; Berberian AA; Scarpato BS; Leclerc E; Teixeira AL; Gama CS; Bressan RA; Brietzke E
J Psychiatr Res; 2013 Oct; 47(10):1376-82. PubMed ID: 23806580
[TBL] [Abstract][Full Text] [Related]
12. Clinical differences between cocaine-dependent patients with and without antisocial personality disorder.
Comín M; Redondo S; Daigre C; Grau-López L; Casas M; Roncero C
Psychiatry Res; 2016 Dec; 246():587-592. PubMed ID: 27839828
[TBL] [Abstract][Full Text] [Related]
13. Antisocial personality disorder, conduct disorder, and substance abuse in schizophrenia.
Mueser KT; Drake RE; Ackerson TH; Alterman AI; Miles KM; Noordsy DL
J Abnorm Psychol; 1997 Aug; 106(3):473-7. PubMed ID: 9241949
[TBL] [Abstract][Full Text] [Related]
14. BDNF and Cortisol in the Diagnosis of Cocaine-Induced Depression.
Fonseca F; Mestre-Pinto JI; Rodríguez-Minguela R; Papaseit E; Pérez-Mañá C; Langohr K; Barbuti M; Farré M; Torrens M;
Front Psychiatry; 2022; 13():836771. PubMed ID: 35370811
[TBL] [Abstract][Full Text] [Related]
15. [Substance use, affective problems and personality traits: test of two association models].
Chakroun N; Doron J; Swendsen J
Encephale; 2004; 30(6):564-9. PubMed ID: 15738859
[TBL] [Abstract][Full Text] [Related]
16. Abnormalities in chemokine levels in schizophrenia and their clinical correlates.
Hong S; Lee EE; Martin AS; Soontornniyomkij B; Soontornniyomkij V; Achim CL; Reuter C; Irwin MR; Eyler LT; Jeste DV
Schizophr Res; 2017 Mar; 181():63-69. PubMed ID: 27650194
[TBL] [Abstract][Full Text] [Related]
17. Altered chemokine levels in the cerebrospinal fluid and plasma of suicide attempters.
Janelidze S; Ventorp F; Erhardt S; Hansson O; Minthon L; Flax J; Samuelsson M; Traskman-Bendz L; Brundin L
Psychoneuroendocrinology; 2013 Jun; 38(6):853-62. PubMed ID: 23062672
[TBL] [Abstract][Full Text] [Related]
18. Cocaine users with antisocial personality improve HIV risk behaviors as much as those without antisocial personality.
Compton WM; Cottler LB; Spitznagel EL; Ben Abdallah A; Gallagher T
Drug Alcohol Depend; 1998 Feb; 49(3):239-47. PubMed ID: 9571388
[TBL] [Abstract][Full Text] [Related]
19. Plasma Lysophosphatidic Acid Concentrations in Sex Differences and Psychiatric Comorbidity in Patients with Cocaine Use Disorder.
Requena-Ocaña N; Flores-López M; García-Marchena N; Pavón-Morón FJ; Pedraza C; Wallace A; Castilla-Ortega E; Rodríguez de Fonseca F; Serrano A; Araos P
Int J Mol Sci; 2023 Oct; 24(21):. PubMed ID: 37958570
[TBL] [Abstract][Full Text] [Related]
20. Sex differences in psychiatric comorbidity and plasma biomarkers for cocaine addiction in abstinent cocaine-addicted subjects in outpatient settings.
Pedraz M; Araos P; García-Marchena N; Serrano A; Romero-Sanchiz P; Suárez J; Castilla-Ortega E; Mayoral-Cleries F; Ruiz JJ; Pastor A; Barrios V; Chowen JA; Argente J; Torrens M; de la Torre R; Rodríguez De Fonseca F; Pavón FJ
Front Psychiatry; 2015; 6():17. PubMed ID: 25762940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
